-
1
-
-
0003661906
-
-
World Health Organization. Available from. Accessed July 5, 2014
-
World Health Organization. World Health Statistics 2008. Available from http://www.who.int/whosis/whostat/2008/en/. Accessed July 5, 2014.
-
World Health Statistics 2008
-
-
-
2
-
-
0027962628
-
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study
-
Anthonisen NR, Connett JE, Kiley JP, et al., Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994; 272: 1497-505.
-
(1994)
JAMA
, vol.272
, pp. 1497-1505
-
-
Anthonisen, N.R.1
Connett, J.E.2
Kiley, J.P.3
-
3
-
-
27144461153
-
COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program
-
Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD,. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005; 128: 2068-75.
-
(2005)
Chest
, vol.128
, pp. 2068-2075
-
-
Sidney, S.1
Sorel, M.2
Quesenberry, C.P.3
DeLuise, C.4
Lanes, S.5
Eisner, M.D.6
-
4
-
-
28944436527
-
Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients
-
Curkendall SM, DeLuise C, Jones JK, et al., Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006; 16: 63-70.
-
(2006)
Ann Epidemiol
, vol.16
, pp. 63-70
-
-
Curkendall, S.M.1
DeLuise, C.2
Jones, J.K.3
-
5
-
-
0037465734
-
Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? the potential role of systemic inflammation in chronic obstructive pulmonary disease
-
Sin DD, Man SFP,. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107: 1514-9.
-
(2003)
Circulation
, vol.107
, pp. 1514-1519
-
-
Sin, D.D.1
Man, S.F.P.2
-
6
-
-
17644407378
-
Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality
-
Sin DD, Man SFP,. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2005; 2: 8-11.
-
(2005)
Proc Am Thorac Soc
, vol.2
, pp. 8-11
-
-
Sin, D.D.1
Man, S.F.P.2
-
9
-
-
84879999170
-
Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease
-
Gershon A, Croxford R, Calzavara A, et al., Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease. JAMA Intern Med 2013; 173: 1175-85.
-
(2013)
JAMA Intern Med
, vol.173
, pp. 1175-1185
-
-
Gershon, A.1
Croxford, R.2
Calzavara, A.3
-
10
-
-
51949090107
-
Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease
-
Lee TA, Pickard AS, Au DH, Bartle B, Weiss KB,. Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease. Ann Intern Med 2008; 149: 380-90.
-
(2008)
Ann Intern Med
, vol.149
, pp. 380-390
-
-
Lee, T.A.1
Pickard, A.S.2
Au, D.H.3
Bartle, B.4
Weiss, K.B.5
-
11
-
-
33847172367
-
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
-
Calverley PMA, Anderson JA, Celli B, et al., Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775-89.
-
(2007)
N Engl J Med
, vol.356
, pp. 775-789
-
-
Calverley, P.M.A.1
Anderson, J.A.2
Celli, B.3
-
12
-
-
84871362143
-
Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications
-
Singh S, Loke YK, Enright P, Furberg CD,. Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications. Thorax 2013; 68: 114-6.
-
(2013)
Thorax
, vol.68
, pp. 114-116
-
-
Singh, S.1
Loke, Y.K.2
Enright, P.3
Furberg, C.D.4
-
13
-
-
52449106502
-
Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease. A systematic review and meta-analysis
-
Singh S, Loke YK, Furberg CD,. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease. A systematic review and meta-analysis. JAMA 2008; 300: 1439-50.
-
(2008)
JAMA
, vol.300
, pp. 1439-1450
-
-
Singh, S.1
Loke, Y.K.2
Furberg, C.D.3
-
14
-
-
68849127359
-
Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease
-
Lee TA, Wilke C, Joo M, et al., Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease. Arch Intern Med 2009; 169: 1403-10.
-
(2009)
Arch Intern Med
, vol.169
, pp. 1403-1410
-
-
Lee, T.A.1
Wilke, C.2
Joo, M.3
-
15
-
-
53749102775
-
A 4-year trial of tiotropium in chronic obstructive pulmonary disease
-
Tashkin DP, Celli B, Senn S, et al., A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 1543-54.
-
(2008)
N Engl J Med
, vol.359
, pp. 1543-1554
-
-
Tashkin, D.P.1
Celli, B.2
Senn, S.3
-
16
-
-
74949134191
-
Cardiovascular safety of tiotropium in patients with COPD
-
Celli B, Decramer M, Leimer I, Vogel U, Kesten S, Tashkin DP,. Cardiovascular safety of tiotropium in patients with COPD. Chest 2010; 137: 20-30.
-
(2010)
Chest
, vol.137
, pp. 20-30
-
-
Celli, B.1
Decramer, M.2
Leimer, I.3
Vogel, U.4
Kesten, S.5
Tashkin, D.P.6
-
17
-
-
79955764009
-
Comparison of inhaled long-acting β agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease
-
Gershon A, Croxford R, To T, et al., Comparison of inhaled long-acting β agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease. Ann Intern Med 2011; 154: 583-92.
-
(2011)
Ann Intern Med
, vol.154
, pp. 583-592
-
-
Gershon, A.1
Croxford, R.2
To, T.3
-
18
-
-
36448935172
-
Comparative safety of long-acting inhaled bronchodilators. A cohort study using the UK THIN primary care database
-
Jara M, Lanes SF, Wentworth C 3rd, May C, Kesten S,. Comparative safety of long-acting inhaled bronchodilators. A cohort study using the UK THIN primary care database. Drug Saf 2007; 30: 1151-60.
-
(2007)
Drug Saf
, vol.30
, pp. 1151-1160
-
-
Jara, M.1
Lanes, S.F.2
Wentworth, C.3
May, C.4
Kesten, S.5
-
19
-
-
84863657697
-
A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD
-
pii: e000841
-
Jara M, Wentworth C, Lanes S,. A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD. BMJ Open 2012; 2:pii: e000841.
-
(2012)
BMJ Open
, vol.2
-
-
Jara, M.1
Wentworth, C.2
Lanes, S.3
-
21
-
-
70350096410
-
Identifying individuals with physician diagnosed COPD in health administrative databases
-
Gershon AS, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T,. Identifying individuals with physician diagnosed COPD in health administrative databases. COPD 2009; 6: 388-94.
-
(2009)
COPD
, vol.6
, pp. 388-394
-
-
Gershon, A.S.1
Wang, C.2
Guan, J.3
Vasilevska-Ristovska, J.4
Cicutto, L.5
To, T.6
-
22
-
-
61449524241
-
Observational studies analyzed like randomized experiments: An application to postmenopausal hormone therapy and coronary heart disease
-
Hernán MA, Alonso A, Logan R, et al., Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology 2008; 19: 766-79.
-
(2008)
Epidemiology
, vol.19
, pp. 766-779
-
-
Hernán, M.A.1
Alonso, A.2
Logan, R.3
-
23
-
-
17844393082
-
Readers' guide to critical appraisal of cohort studies: 2. Assessing potential for confounding
-
Mamadani M, Sykora K, Li P, et al., Readers' guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ 2005; 330: 960-2.
-
(2005)
BMJ
, vol.330
, pp. 960-962
-
-
Mamadani, M.1
Sykora, K.2
Li, P.3
-
24
-
-
84877682284
-
Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease
-
Tashkin DP, Ferguson GT,. Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease. Respir Res 2013; 14: 49.
-
(2013)
Respir Res
, vol.14
, pp. 49
-
-
Tashkin, D.P.1
Ferguson, G.T.2
-
25
-
-
79953166862
-
Tiotropium versus salmeterol for the prevention of exacerbations of COPD
-
Vogelmeier C, Hederer B, Glaab T, et al., Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med 2011; 364: 1093-103.
-
(2011)
N Engl J Med
, vol.364
, pp. 1093-1103
-
-
Vogelmeier, C.1
Hederer, B.2
Glaab, T.3
-
26
-
-
84871396857
-
Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: Systematic review and mixed treatment comparison meta-analysis of randomized controlled trials
-
Dong YH, Lin HH, Shau WY, Wu YC, Chang CH, Lai MS,. Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomized controlled trials. Thorax 2013; 68: 48-56.
-
(2013)
Thorax
, vol.68
, pp. 48-56
-
-
Dong, Y.H.1
Lin, H.H.2
Shau, W.Y.3
Wu, Y.C.4
Chang, C.H.5
Lai, M.S.6
-
27
-
-
34247561439
-
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: A randomized trial
-
Aaron SD, Vandemheen KL, Fergusson D, et al., Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2007; 146: 545-55.
-
(2007)
Ann Intern Med
, vol.146
, pp. 545-555
-
-
Aaron, S.D.1
Vandemheen, K.L.2
Fergusson, D.3
-
28
-
-
84865284777
-
Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: A randomised, double-blind comparison
-
Mahler DA, D'Urzo A, Bateman ED, et al., Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison. Thorax 2012; 67: 781-8.
-
(2012)
Thorax
, vol.67
, pp. 781-788
-
-
Mahler, D.A.1
D'Urzo, A.2
Bateman, E.D.3
-
31
-
-
84877131237
-
Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): A randomized, double-blind, parallel-group study
-
Wedzicha JA, Decramer M, Ficker JH, et al., Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomized, double-blind, parallel-group study. Lancet Respir Med 2013; 1: 199-209.
-
(2013)
Lancet Respir Med
, vol.1
, pp. 199-209
-
-
Wedzicha, J.A.1
Decramer, M.2
Ficker, J.H.3
-
33
-
-
84880229392
-
Dual bronchodilation with QVA149 versus single bronchodilator therapy: The SHINE study
-
Bateman ED, Ferguson GT, Barnes N, et al., Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study. Eur Respir J 2013; 42: 1484-94.
-
(2013)
Eur Respir J
, vol.42
, pp. 1484-1494
-
-
Bateman, E.D.1
Ferguson, G.T.2
Barnes, N.3
-
35
-
-
84926409166
-
Clinical and lifestyle-related risk factors for incident multimorbidity: 10-year follow-up of Finnish population-based cohorts 1982-2012
-
Wikström K, Lindström J, Harald K, Peltonen M, Laatikainen T,. Clinical and lifestyle-related risk factors for incident multimorbidity: 10-year follow-up of Finnish population-based cohorts 1982-2012. Eur J Intern Med 2015; 26: 211-6.
-
(2015)
Eur J Intern Med
, vol.26
, pp. 211-216
-
-
Wikström, K.1
Lindström, J.2
Harald, K.3
Peltonen, M.4
Laatikainen, T.5
-
36
-
-
84862802007
-
Complexity of medication use in newly diagnosed chronic obstructive pulmonary disease patients
-
Solem CT, Lee TA, Joo MJ, Lambert BL, Walton SM, Pickard AS,. Complexity of medication use in newly diagnosed chronic obstructive pulmonary disease patients. Am J Geriatr Pharmacother 2012; 10: 110-22.
-
(2012)
Am J Geriatr Pharmacother
, vol.10
, pp. 110-122
-
-
Solem, C.T.1
Lee, T.A.2
Joo, M.J.3
Lambert, B.L.4
Walton, S.M.5
Pickard, A.S.6
|